Pharma Stock Market Review
Big Pharma Stocks
Trending Biotech Stocks
Latest Pharma Stock Updates
![](https://pharma-industry-review.com/wp-content/uploads/2024/01/Untitled-design-47-392x272.png)
Bristol Myers Squibb Acquires Radiopharma Company RayzeBio
Bristol Myers Squibb has added a premier radiopharmaceutical platform to its portfolio with the acquisition of RayzeBio, a radiopharmaceutical therapeutics
![](https://pharma-industry-review.com/wp-content/uploads/2022/02/ian-hutchinson-iuiKtPNHObA-unsplash-392x272.jpg)
Moderna’s ‘Spikevax’ COVID-19 Vaccine Gets Full FDA Approval
The U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
![covid](https://pharma-industry-review.com/wp-content/uploads/2022/01/cdc-bkc-m0iZ4Sk-unsplash-392x272.jpg)
Evotec Wins € 7.5 Mill Grant for Development of First-in-class COVID-19 Therapeutic
Evotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
![decorative](https://pharma-industry-review.com/wp-content/uploads/2021/09/analysis-4937349_1920-392x272.jpg)
Valneva Stock Price Drops 40% as UK cancels vaccine deal
Valneva shares dropped by around 40% in early trading on Monday as the UK government announced its intention to withdraw
![covid shares](https://pharma-industry-review.com/wp-content/uploads/2021/05/maxim-hopman-fiXLQXAhCfk-unsplash-392x272.jpg)
Covid Vaccine Shares Hit by US Administration Decision to Wave Patents
The announced temporary waiver of COVID-19 vaccine patents by Joe Biden’s administration has hit vaccine maker shares and raised serious
![decorative](https://pharma-industry-review.com/wp-content/uploads/2021/04/investment-5241253_1920-392x272.jpg)
Evotec Invests in Oxford University Spinout Cell Therapy Company OxVax
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) revealed that it has invested in OxVax, a new immuno-oncology organization
![drug resistant bacteria](https://pharma-industry-review.com/wp-content/uploads/2021/04/bacteria-3658992_1280-800x445-1-392x272.jpg)
Phico Therapeutics Awarded up to $18.2 Million Funding to Advance Antibacterial Therapy
Phico Therapeutics (‘Phico’), a British biotech company developing engineered phage technologies as the foundation of a new wave of antibiotics
![](https://pharma-industry-review.com/wp-content/uploads/2021/04/Newsroom-Photos-Company-1-392x272.jpg)
Thermo Fisher to Acquire CRO giant PPD for $17.4 Billion in Cash
Thermo Fisher Scientific expands clinical research service offering to pharma and biotech customers with a CRO giant PPD acquisition. Thermo
![](https://pharma-industry-review.com/wp-content/uploads/2021/04/julia-koblitz-RlOAwXt2fEA-unsplash-392x272.jpg)
Evotec Launches the First Translational BRIDGE in Germany in Collaboration with Bristol-Myers
Evotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
![](https://pharma-industry-review.com/wp-content/uploads/2020/10/national-cancer-institute-TX9pU27p6D0-unsplash-3-392x272.jpg)
Phenomic AI starts with $6M using AI/ML for Targeting the Tumor Stroma
Phenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6
Advertisement